Advertisement

Radiation and Environmental Biophysics

, Volume 58, Issue 1, pp 1–11 | Cite as

The State Scientific Automated Medical Registry, Kazakhstan: an important resource for low-dose radiation health research

  • K. N. Apsalikov
  • A. Lipikhina
  • B. GroscheEmail author
  • T. Belikhina
  • E. Ostroumova
  • S. Shinkarev
  • V. Stepanenko
  • T. Muldagaliev
  • S. Yoshinaga
  • T. Zhunussova
  • M. Hoshi
  • H. Katayama
  • D. T. Lackland
  • S. L. Simon
  • A. Kesminiene
Review

Abstract

Direct quantitative assessment of health risks following exposure to ionizing radiation is based on findings from epidemiological studies. Populations affected by nuclear bomb testing are among those that allow such assessment. The population living around the former Soviet Union’s Semipalatinsk nuclear test site is one of the largest human cohorts exposed to radiation from nuclear weapons tests. Following research that started in the 1960s, a registry that contains information on more than 300,000 individuals residing in the areas neighboring to the test site was established. Four nuclear weapons tests, conducted from 1949 to 1956, resulted in non-negligible radiation exposures to the public, corresponding up to approximately 300 mGy external dose. The registry contains relevant information about those who lived at the time of the testing as well as about their offspring, including biological material. An international group of scientists worked together within the research project SEMI-NUC funded by the European Union, and concluded that the registry provides a novel, mostly unexplored, and valuable resource for the assessment of the population risks associated with environmental radiation exposure. Suggestions for future studies and pathways on how to use the best dose assessment strategies have also been described in the project. Moreover, the registry could be used for research on other relevant public health topics.

Keywords

Health effects Kazakhstan Nuclear bomb testing Population registry Ionizing radiation 

Notes

Acknowledgements

The work was partly funded by FP7-EURATOM-Fission under contract 323310.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Akleyev AV, Grosche B, Gusev BI, Kiselev VI, Kisselev MF, Kolyado IB, Romanov S, Shoikhet YN, Neta R (2002) Developing additional resources. Radiat Environ Biophys 41:13–18CrossRefGoogle Scholar
  2. Apsalikov K (2016) 3-Generation exposure study: data and biomaterial for studying transgenerational effects. AIR2 access to infrastructures for radiation protection research, p 5. http://www.concert-h2020.eu/~/media/Files/Concert/AIR2/Infrastructures_AIR2_Bulletin_5_March_2016.pdf?la=en. Accessed 1 Nov 2018
  3. Apsalikov AN, Grosche B, Kesminiene A (2015) High stroke risk in Kazakh population. WHL Newsletter, p 147. http://www.whleague.org/images/WHL_March_2015_Newsletter.pdf
  4. Apsalikov KN, Gusev BI, Lipikhina AV, Muldagaliyev TZ, Belikhina TI, Zhakupova SB (2016) Historical aspects of formation of radiation medicine and ecology in Kazakhstan. Radiat Med Ecol Rehabil 1:5–11Google Scholar
  5. Apsalikov KN, Lipikhina AV, Grosche B, Mansarina AE, Zhakupova SB, Zharmukhambetova AK (2017) The State Scientific Automated Medical Register: an unique infrastructure for trans-generational studies of low-dose radiation effects. Radiat Med Ecol Rehabil 1:5–9Google Scholar
  6. Bauer S, Gusev BI, Pivina LM, Apsalikov KN, Grosche B (2005) Radiation exposure due to local fallout from Soviet atmospheric nuclear weapons testing in Kazakhstan: solid cancer mortality in the Semipalatinsk historical cohort, 1960–1999. Radiat Res 164:409–419ADSCrossRefGoogle Scholar
  7. Bauer S, Gusev B, Belikhina T, Moldagaliev T, Apsalikov A (2013) The legacies of soviet nuclear testing in Kazakhstan fallout, public health and societal issues. Radioact Environ 19:241–258CrossRefGoogle Scholar
  8. Beck HL, Anspaugh LR, Bouville A, Simon SL (2006) Review of methods of dose estimation for epidemiological studies of the radiological impact of Nevada test site and global fallout. Radiat Res 166:209–218ADSCrossRefGoogle Scholar
  9. Drozdovitch V, Schonfeld S, Akimzhanov K, Aldyngurov D, Land CE, Luckyanov N, Mabuchi K, Potischman N, Schwerin MJ, Semenova Y, Tokaeva A, Zhumadilov Z, Bouville A, Simon SL (2011) Behavior and food consumption pattern of the population exposed in 1949–1962 to fallout from Semipalatinsk nuclear test site in Kazakhstan. Radiat Environ Biophys 50:91–103CrossRefGoogle Scholar
  10. Dubasov YV, Zelentsov SA, Matushchenko AM, Tsyrkov TA, Logachev VA, Chernyshov AK (1994) Chronology of nuclear testing at the Semipalatinsk Polygon and the radiation characteristics of nuclear tests. In: Radioactivity from nuclear test explosions: the human and environmental consequences. Institute of Regional Medico-Ecological Problems, BarnaulGoogle Scholar
  11. Dyussenova L, Pivina L, Semenova Y, Bjørklund G, Glushkova N, Chirumbolo S, Belikhina T (2018) Associations between depression, anxiety and medication adherence among patients with arterial hypertension: comparison between persons exposed and non-exposed to radiation from the Semipalatinsk Nuclear Test Site. J Environ Radioact 195:33–39CrossRefGoogle Scholar
  12. Gilbert ES, Land CE, Simon SL (2002) Health effects from fallout. Health Phys 82:726–735CrossRefGoogle Scholar
  13. Glushkova NE, Rakhypbekov TK, Apsalikov KN, Sandybayev MN, Apsalikov B, Madiyeva MR, Baildinova K, Tanysheva GA, Pivina LM, Belikhina TI, Alimbayeva AR, Smailova K, Toktarova K, Andreyeva OB (2015) Cancer effects in the offspring of the people exposed to radiation in Kazakhstan. Eur J Public Health 25(Suppl 3):e277–e278Google Scholar
  14. Gordeev K, Vasilenko I, Lebedev A, Bouville A, Luckyanov N, Simon SL, Stepanov Y, Shinkarev S, Anspaugh L (2002) Fallout from nuclear tests: dosimetry in Kazakhstan. Radiat Environ Biophys 41:61–68CrossRefGoogle Scholar
  15. Gordeev K, Shinkarev S, Ilyin L, Bouville A, Hoshi M, Luckyanov N, Simon SL (2006a) Retrospective dose assessment for the population living in areas of local fallout from the Semipalatinsk nuclear test site part I: external exposure. J Radiat Res 47(Suppl A):A129–A136CrossRefGoogle Scholar
  16. Gordeev K, Shinkarev S, Ilyin L, Bouville A, Hoshi M, Luckyanov N, Simon SL (2006b) Retrospective dose assessment for the population living in areas of local fallout from the Semipalatinsk nuclear test site part II: internal exposure to thyroid. J Radiat Res 47(Suppl A):A137–A141CrossRefGoogle Scholar
  17. Grosche B (2013) Risk to populations exposed from atmospheric testing and those residing near nuclear facilities. In: Reference module in earth systems and environmental sciences. Elsevier, AmsterdamGoogle Scholar
  18. Grosche B, Lackland DT, Land CE, Simon SL, Apsalikov KN, Pivina LM, Bauer S, Gusev BI (2011) Mortality from cardiovascular diseases in the Semipalatinsk historical cohort, 1960–1999, and its relationship to radiation exposure. Radiat Res 176:660–669ADSCrossRefGoogle Scholar
  19. Grosche B, Zhunussova T, Apsalikov K, Kesminiene A (2015) Studies of health effects from nuclear testing near the Semipalatinsk Nuclear Test Site, Kazakhstan. Cent Asian J Glob Health 4:1–7Google Scholar
  20. Grosche B, Simon SL, Apsalikov KN, Kesminiene A (2016) Radiation health risk studies associated with nuclear testing in Kazakhstan. In: Freedman E, Neuzil M (eds) Environmental crisis in Central Asia. Routledge, London, pp 117–126Google Scholar
  21. Grosche B, Katayama H, Hoshi M, Apsalikov KN, Belikhina T, Noso Y, Takeichi N (2017) Thyroid diseases in populations residing near the Semipalatinsk Nuclear Test Site, Kazakhstan: results from an 11 years series of medical examinations. SM J Public Health Epidemiol 3:1038Google Scholar
  22. Gusev BI, Abylkassimova ZN, Apsalikov KN (1997) The Semipalatinsk nuclear test site: a first assessment of the radiological situation and the test-related radiation doses in the surrounding territories. Radiat Environ Biophys 36:201–204CrossRefGoogle Scholar
  23. Hamada A, Chaizhunusova NJ, Saenko VA, Rogounovitch TI, Takamura N, Namba H, Apsalikov KN, Yamashita S (2004) No increase of large-scale mitochondrial DNA deletions in peripheral blood cells in residents of Kazakhstan around Semipalatinsk nuclear test site. Acta Medica Nagasakiensia 49:45–49Google Scholar
  24. Katayama H, Apsalikov KN, Gusev BI, Galich B, Madieva M, Koshpessova G, Abdikarimova A, Hoshi M (2006) An attempt to develop a database for epidemiological research in Semipalatinsk. J Radiat Res 47(Suppl A):A189–A197CrossRefGoogle Scholar
  25. Kesminiene A (2016) SEMI-NUC Report Summary. http://cordis.europa.eu/result/rcn/189405_en.html. Accessed 12 Oct 2018
  26. Kurakina NN, Sekerbaev AK, Gusev BI, Ospanov EK (2000) Otsenka pogloshchennikh i effektivnykh doz ioniziruiushchikh izluchenii u naseleniia, prozhivaiushchego na radioaktivnikh sledakh iadernikh vzryvov. Metodicheskie ukazaniia dlia spetsialistov po radiatsionnoi meditsine i radioekologii [Assessment of absorbed and effective radiation doses in the population living on the radioactive traces of nuclear tests. Methodological guidelines for experts in radiation medicine and ecology]. Semipalatinsk/AlmatyGoogle Scholar
  27. Land CE, Zhumadilov Z, Gusev BI, Hartshore MH, Wiest PW, Woodward PW, Crooks LA, Luckyanov NK, Fillmore CM, Carr Z, Abisheva G, Beck HL, Bouville A, Langer J, Weinstock R, Gordeev KI, Shinkarev S, Simon SL (2008) Ultrasound-detected thyroid nodule prevalence and radiation dose from fallout. Radiat Res 169:373–383ADSCrossRefGoogle Scholar
  28. Land CE, Kwon D, Hoffman FO, Moroz B, Drozdovitch V, Bouville A, Beck H, Luckynov N, Weinstock RM, Simon SL (2015) Accounting for shared and unshared dosimetric uncertainties in the dose response for ultrasound-detected thyroid nodules after exposure to radioactive fallout. Radiat Res 183:159–173ADSCrossRefGoogle Scholar
  29. Markabayeva A, Kerimkulova A, Pivina L, Belikhina T, Muldagaliev T, Khaibullin T, Akhmetova A, Maukayeva S, Akimzhanova A, Kudaibergenova N (2015a) Ethnic and gender differences in the prevalence of overweight and obesity in East Kazakhstan. J Hypertension 33(e-Suppl 1):e519CrossRefGoogle Scholar
  30. Markabayeva A, Kerimkulova A, Weber V, Moldagaliyeva J, Rakhypbekov T, Pivina L (2015b) Study of the prevalence of hypertension and risk factors among residents of areas adjoining to Semipalatsink Nuclear Test Site. J Hypertension 33(e-Suppl 1):e393CrossRefGoogle Scholar
  31. Mikhailov VN (1996) Nuclear weapons tests and peaceful nuclear explosions in the USSR 1949–1990. Ministry of the Russian Federation on Atomic Energy and Ministry of Defense of the Russian Federation, MoscowGoogle Scholar
  32. Mudie NY, Gusev BI, Pivina LM, Schoemaker MJ, Rijinkova ON, Apsalikov KN, Swerdlow AJ (2007) Sex ratio in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. Radiat Res 168:600–607ADSCrossRefGoogle Scholar
  33. Mudie NY, Swerdlow AJ, Gusev BI, Schoemaker MJ, Pivina LM, Chsherbakova S, Mansarina A, Bauer S, Jakovlev Y, Apsalikov KN (2010) Twinning in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. Radiat Res 173:829–836ADSCrossRefGoogle Scholar
  34. Nugent RW, Zhumadilov ZS, Gusev BI, Hoshi M (2000) Study of health effects of radiation associated with nuclear weapons testing at the Semipalatinsk test site. Makamoto Sogo Printing Co., HiroshimaGoogle Scholar
  35. Ogiu T, Aoki Y, Kobayashi S, Kusumi S, Inaba J, Kenzhina G, Berezin S, Zhotabaev Zh, Berezina M, Sekerbayev A, Lukashenko S (2008) Kazakhstan-Japan joint study on health effects of radiation in residents in and around former Semipalatinsk Nuclear Test Site. In: Paper presented at the 3. International scientific-practical conference ‘Semipalatinsk Test Site. Radiation Legacy and Non-proliferation Issues’, KurchatovGoogle Scholar
  36. Pivina LM, Rakhypbekov TK, Dyussupov AA, Belikhina TI, Semenova YuM, Manatova AM, Aukenov NE, Baildinova K, Glushkova NE (2017a) Anxiety and somatoform disorder in the descendants of people exposed to radiation in Kazakhstan. Eur J Public Health 27(Suppl 3):311–312Google Scholar
  37. Pivina LM, Semenova YM, Rakhypbekov TK, Dyussupov AltA, Belikhina TI, Manatova AM, Aukenov NE, Baildinova K, Glushkova NE (2017b) Prevalence of depression in the offspring of people exposed to radiation in East Kazakhstan. Eur J Public Health 27(Suppl 3):388–389Google Scholar
  38. Salomaa S, Averbeck D, Ottolenghi A, Sabatier L, Bouffler S, Atkinson M, Jourdain JR (2015) European low-dose radiation risk research strategy: future of research on biological effects at low doses. Radiat Prot Dosim 164:38–41CrossRefGoogle Scholar
  39. Shoikhet YN, Kiselev VI, Algazin AI, Kolyado IB, Bauer S, Grosche B (2002) Fallout from nuclear tests: health effects in the Altai region. Radiat Environ Biophys 41:69–73CrossRefGoogle Scholar
  40. Sigurdson AJ, Land CE, Bhatti P, Pineda M, Brenner A, Carr Zh, Gusev BI, Zhumadilov Z, Simon SL, Bouville A, Rutter JL, Ron E, Struewing JP (2009) Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res 171:77–88ADSCrossRefGoogle Scholar
  41. Simon SL, Beck HL, Gordeev K, Bouville A, Anspaugh LR, Land CE, Luckyanov N, Shinkarev S (2006) External dose estimates for Dolon village: application of the U.S./Russian joint methodology. J Radiat Res (Tokyo) 47(Suppl A):A143–A147CrossRefGoogle Scholar
  42. Stepanenko VF, Hoshi M, Bailiff IK, Ivannikov AI, Toyoda S, Yamamoto M, Simon SL, Matsuo M, Kawano N, Zhumadilov Z, Sasaki MS, Rosenson RI, Apsalikov KN (2006) Around Semipalatinsk nuclear test site: progress of dose estimations relevant to the consequences of nuclear tests (a summary of 3rd Dosimetry Workshop on the Semipalatinsk nuclear test site area, RIRBM, Hiroshima University, Hiroshima, 9–11 of March, 2005). J Radiat Res 47(Suppl A):A1–A13CrossRefGoogle Scholar
  43. Takeichi N, Hoshi M, Iida S, Tanaka K, Harada Y, Zhumadilov Z, Chaizhunusova N, Apsalikov KN, Noso Y, Inaba T, Tanaka K, Endo S (2006) Nuclear abnormalities in aspirated thyroid cells and chromosome aberrations in lymphocytes of residents near the Semipalatinsk nuclear test site. J Radiat Res 47(Suppl A):A171–A177CrossRefGoogle Scholar
  44. Tanaka K, Iida S, Takeichi N, Chaizhunusova NJ, Gusev BI, Apsalikov KN, Inaba T, Hoshi M (2006) Unstable-type chromosome aberrations in lymphocytes from individuals living near Semipalatinsk nuclear test site. J Radiat Res 47(Suppl A):A159–A164CrossRefGoogle Scholar
  45. UNSCEAR (2000) Sources and effects of ionizing radiation. Volume I: sources. United Nations, ViennaGoogle Scholar
  46. UNSCEAR (2008) Sources and effects of ionizing radiation. United Nations, ViennaGoogle Scholar
  47. Vakulchuk R, Gjierde K, Belikhina T, Apsalikov K (2014) Semipalatinsk nuclear testing: the humanitarian consequences. Norwegian Institute of International Affairs, OsloGoogle Scholar
  48. Yoshinaga S, Ishida J, Inaba J, Baigazinov Z, Berezina MV, Kenzhina GT, Berezin SA, Ogiu T (2018) Populations living near the semipalatinsk test site: a new cohort for assessing health effects from protracted exposures to low-to-moderate doses of radiation. Japan J Health Phys 53:163–168CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • K. N. Apsalikov
    • 1
  • A. Lipikhina
    • 1
  • B. Grosche
    • 2
    • 3
    Email author
  • T. Belikhina
    • 1
  • E. Ostroumova
    • 4
  • S. Shinkarev
    • 5
  • V. Stepanenko
    • 6
  • T. Muldagaliev
    • 1
  • S. Yoshinaga
    • 7
  • T. Zhunussova
    • 8
  • M. Hoshi
    • 9
  • H. Katayama
    • 10
  • D. T. Lackland
    • 11
  • S. L. Simon
    • 12
  • A. Kesminiene
    • 4
  1. 1.Scientific Research Institute for Radiation Medicine and EcologySemeyKazakhstan
  2. 2.Federal Office for Radiation ProtectionNeuherbergGermany
  3. 3.FreisingGermany
  4. 4.International Agency for Research on CancerLyon Cedex 08France
  5. 5.State Research Center–Burnasyan Federal Medical Biophysical CenterMoscowRussian Federation
  6. 6.A. Tsyb Medical Radiological Research CenterObninskRussian Federation
  7. 7.Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
  8. 8.Norwegian Radiation Protection AuthorityOsteraasNorway
  9. 9.Institute for Peace ScienceHiroshima UniversityHiroshimaJapan
  10. 10.The Comprehensive Data Archives and Analysis (CDAA)HiroshimaJapan
  11. 11.Medical University of South CarolinaCharlestonUSA
  12. 12.Division of Cancer Epidemiology and GeneticsNational Cancer Institute, National Institutes of HealthBethesdaUSA

Personalised recommendations